Shu Yun Lin

Oneness Innovation Investment Co., Ltd. is an investment holding Taiwanese company founded in 2007. The private company is based in Taipei, Taiwan. The company operates as an investment holding company.

Stemcyte Taiwan, founded in 2000, is a private company based in New Taipei City, Taiwan that specializes in umbilical cord blood banking. Stemcyte Taiwan has been recognized by over 350 medical centers worldwide and has helped with over 2,500 cord blood transplants. The Taiwanese company has a large public cord blood bank and exclusive patent technology for red blood cell separation. Stemcyte Taiwan has received international accreditations from AABB, FACT, NMDP, WMDA, and FDA, providing customers with secure and transparent contracts.

Stemcyte Taiwan, founded in 2000, is a private company based in New Taipei City, Taiwan that specializes in umbilical cord blood banking. Stemcyte Taiwan has been recognized by over 350 medical centers worldwide and has helped with over 2,500 cord blood transplants. The Taiwanese company has a large public cord blood bank and exclusive patent technology for red blood cell separation. Stemcyte Taiwan has received international accreditations from AABB, FACT, NMDP, WMDA, and FDA, providing customers with secure and transparent contracts.

Stemcyte Taiwan, founded in 2000, is a private company based in New Taipei City, Taiwan that specializes in umbilical cord blood banking. Stemcyte Taiwan has been recognized by over 350 medical centers worldwide and has helped with over 2,500 cord blood transplants. The Taiwanese company has a large public cord blood bank and exclusive patent technology for red blood cell separation. Stemcyte Taiwan has received international accreditations from AABB, FACT, NMDP, WMDA, and FDA, providing customers with secure and transparent contracts.

Stemcyte Taiwan, founded in 2000, is a private company based in New Taipei City, Taiwan that specializes in umbilical cord blood banking. Stemcyte Taiwan has been recognized by over 350 medical centers worldwide and has helped with over 2,500 cord blood transplants. The Taiwanese company has a large public cord blood bank and exclusive patent technology for red blood cell separation. Stemcyte Taiwan has received international accreditations from AABB, FACT, NMDP, WMDA, and FDA, providing customers with secure and transparent contracts.

Stemcyte Taiwan, founded in 2000, is a private company based in New Taipei City, Taiwan that specializes in umbilical cord blood banking. Stemcyte Taiwan has been recognized by over 350 medical centers worldwide and has helped with over 2,500 cord blood transplants. The Taiwanese company has a large public cord blood bank and exclusive patent technology for red blood cell separation. Stemcyte Taiwan has received international accreditations from AABB, FACT, NMDP, WMDA, and FDA, providing customers with secure and transparent contracts.